Spanish Academic Spinout Digna Biotech In Development Deal With Flamel
This article was originally published in The Pink Sheet Daily
Executive Summary
Digna Biotech is enhancing three early stage compounds with Flamel's technologies for development of drugs aimed at pulmonary fibrosis, liver cirrhosis and multiple sclerosis.